Cover Image

Guidance for industry : ANDAs, pharmaceutical solid polymorphism, chemistry, manufacturing and controls information.

Bibliographic Details
Corporate Author:	Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2007]
Subjects:	Polymorphism (Crystallography) Drug factories > Government policy > United States. Drug stability > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS117065

Similar Items

Guidance for industry : PAT, a framework for innovative pharmaceutical development, manufacturing, and quality assurance.
Published: (2004)

Guidance for industry : Q1B photostability testing of new drug substances and products.
Published: (1996)

Polymorphism and polytypism in crystals /
by: Verma, Ajit Ram, et al.
Published: (1966)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Guidance for industry : formal dispute resolution : scientific and technical issues related to pharmaceutical CGMP.
Published: (2006)

Advances in Chemical Physics, Liquid Polymorphism.
by: Stanley, H. E.
Published: (2013)

Guidance for industry : ANDAs, impurities in drug products.
Published: (2005)

Guidance for industry : ANDAs, impurities in drug substances.
Published: (2009)

Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Published: (2009)

Polymorphism in molecular crystals /
by: Bernstein, Joel, 1941-2019
Published: (2002)

Polymorphism in molecular crystals /
by: Bernstein, Joel, 1941-2019
Published: (2007)

Polymorphism in molecular crystals /
by: Bernstein, Joel, 1941-2019
Published: (2020)

Polymorphism in molecular crystals /
by: Bernstein, Joel, 1941-2019
Published: (2020)

Guidance for industry : revising and ANDA labeling following revision of the RLD labeling.
Published: (2000)

Guidance for industry : submitting type V drug master files to the Center for Biologics Evaluation and Research.
Published: (2001)

Guidance for industry : expiration dating and stability testing of solid oral dosage form drugs containing iron.
Published: (1997)

Guidance for industry : manufacturing, processing, or holding active pharmaceutical ingredients.
Published: (1998)

Polymorphism in condensed matter model systems : recent progress via scale-bridging modeling /
Published: (2007)

Guidance for industry : Q8(R2) pharmaceutical development.
Published: (2009)

Guidance for industry : Q3A impurities in new drug substances.
Published: (2008)

Guidance for industry : Q3B(R2) impurities in new drug products.
Published: (2006)

Guidance for industry : street drug alternatives.
Published: (2000)

Guidance for industry : M4Q, the CTD, quality.
Published: (2001)

Guidance for industry : providing regulatory submissions in electronic format, prescription drug advertising and promotional labeling.
Published: (2001)

Guidance for industry : INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information.
Published: (2003)

Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.
Published: (2006)

Guidance for industry : M4, organization of the CTD.
Published: (2001)

Guidance for industry : formal meetings between the FDA and sponsors or applicants.
Published: (2009)

Guidance for industry : SPL standard for content of labeling technical Qs & As.
Published: (2009)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : dosage delivery devices for OTC liquid drug products.
Published: (2009)

Guidance for industry : court decisions, ANDA approvals, and 180-day exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act.
Published: (2000)

Guidance for industry : fast track drug development programs, designation, development and application review.
Published: (2006)

Guidance for industry : fast track drug development programs, designation, development and application review.
Published: (2004)

Guidance for industry : bar code label requirements, questions and answers.
Published: (2006)

Guidance for industry : IND meetings for human drugs and biologics, chemistry, manufacturing, and controls information.
Published: (2001)

Guidance for industry : submitting and reviewing complete responses to clinical holds.
Published: (2000)

Guidance for industry : format and content for the CMC section of an annual report.
Published: (1994)

Guidance for industry : providing regulatory submissions in electronic format, content of labeling.
Published: (2005)

Guidance for industry : bioequivalence recommendations for specific products.
Published: (2007)